Loretta J. Nastoupil, MD is an Associate Professor in the Department of Lymphoma/Myeloma at the University of Texas MD Anderson Cancer Center in Houston, TX USA. Dr. Nastoupil received her medical degree from the University of Texas Southwestern Medical School and completed her internal medicine training at Washington University and hematology/medical oncology fellowship at Emory University. She is currently Deputy Chair of the Lymphoma/Myeloma Department and Section Chief of the indolent lymphoma and new drug development teams which are in line with her research interests of designing and conducting prospective trials aimed at exploiting the immune system to eradicate B-cell lymphoma. She has led phase 1, 2, and 3 trials in follicular and diffuse large B-cell lymphoma. She is also interested in real world evidence and has been involved in exploring outcomes among patients treated with standard of care CAR T cell therapy and generating synthetic control arms for single arm phase 2 studies.